文献速递围术期管理与 ERAS

择期腹主动脉瘤修复术后他汀治疗改善长期生存

Statin therapy after elective abdominal aortic aneurysm repair improves long-term survival.
PubMed 文献 · Br J Surg · 2024-01-01

基于瑞典全国登记数据,对2006至2018年择期腹主动脉瘤修复患者进行倾向性评分匹配队列分析。术前他汀使用未降低90天围术期死亡率(OR 0.99,95%CI 0.77-1.28),术后他汀使用与长期生存显著获益相关(HR 1.43,95%CI 1.34-1.54),高强度他汀较低-中等强度无额外生存优势(HR 1.00,95%CI 0.80-1.25)。

要点

  • 术前他汀使用未改善择期腹主动脉瘤修复90天围术期死亡率。
  • 术后他汀使用与长期生存改善相关(HR 1.43,95%CI 1.34-1.54)。
  • 高强度他汀较低-中等强度他汀无长期生存额外获益(HR 1.00,95%CI 0.80-1.25)。

核心结论

  • 术前他汀治疗对90天围术期生存无获益,但术后他汀治疗显著改善长期生存。
  • 本分析未能证实高强度他汀治疗有额外获益。

研究设计与样本

  • 全国性倾向性评分匹配队列研究,数据来自瑞典全国登记库,纳入2006至2018年择期腹主动脉瘤修复患者。
  • 分析三个独立倾向性评分匹配队列:术前他汀使用与围术期死亡率、随访期他汀使用与长期生存、术后高强度与低-中等强度他汀与长期生存。

主要发现

  • 术前他汀使用未降低90天围术期死亡率(OR 0.99,95%CI 0.77-1.28)。
  • 术后他汀使用者长期生存显著获益(HR 1.43,95%CI 1.34-1.54)。
  • 高强度他汀较低-中等强度他汀对长期生存无优势(HR 1.00,95%CI 0.80-1.25)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with abdominal aortic aneurysms are at high risk of cardiovascular events. Although statin therapy is indicated for most of these patients, no specific recommendation regarding the intensity of therapy exists. The aim of this study was to assess the possible effect of statin therapy on survival of patients undergoing abdominal aortic aneurysm repair and to investigate if high-intensity statin therapy was superior to low-moderate-intensity therapy. METHODS: Data from nationwide Swedish registers on hospital admissions, operations, and medications for patients undergoing elective abdominal aortic aneurysm repair from 2006 to 2018 were collected. The effect of statin use was evaluated in three separate propensity score matched cohorts: perioperative mortality was analysed according to whether patients were on statins before abdominal aortic aneurysm repair or not; long-term survival was assessed according to whether patients were on statins during follow-up or not; and, for those on statins after surgery, long-term survival was analysed according to whether patients were on high-intensity or low-moderate-intensity statin therapy. RESULTS: Preoperative statin use did not reduce 90-day perioperative mortality (OR 0.99, 95% c.i. 0.77 to 1.28), whilst there was a marked benefit regarding long-term survival for postoperative statin users (HR 1.43, 95% c.i. 1.34 to 1.54). High-intensity statin therapy had no advantage over low-medium-intensity statin therapy with regards to long-term survival (HR 1.00, 95% c.i. 0.80 to 1.25). CONCLUSION: In this nationwide propensity score matched cohort study, preoperative statin treatment had no benefit regarding 90-day perioperative survival, but postoperative statin treatment markedly improved long-term survival. No additional benefit regarding high-dose statin treatment could be confirmed in this analysis.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Lilja F, Wanhainen A, Mani K, et al. Statin therapy after elective abdominal aortic aneurysm repair improves long-term survival. Br J Surg. 2024. PMID: 38198155. doi:10.1093/bjs/znad383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。